Mclean Hospital

Should the FDA Reclassify Marijuana?

April 29, 2016

Washington Post

“Moving marijuana to Schedule II ‘to promote research’ is conceivably unethical, as marijuana would then be designated a safe and effective medicine in the absence of high-quality evidence.” – Dr. Bertha Madras